CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Collaboration arrangement revenue	$ 0	$ 2,947
Operating expenses:
Research and development	9,841	7,910
General and administrative	5,002	2,410
Total operating expenses	14,843	10,320
Loss from operations	(14,843)	(7,373)
Change in fair value of convertible notes	15,890	(43)
Other income (expense), net	158	578
Total other income (expense), net	16,048	535
Income (loss) before provision for income taxes	1,205	(6,838)
Loss from equity method investment	(176)	0
Net income (loss)	$ 1,029	$ (6,838)
Net income (loss) per share - basic	$ 1.03	$ (19.84)
Net income (loss) per share - diluted	$ (6.33)	$ (19.84)
Weighted-average common shares - basic	995,280	344,623
Weighted-average common shares - diluted	2,334,180	344,623